Sign In



Remember Me

MedlinePlus®

A service of the National Library of Medicine.

MerckSource received the 2006 WebAward for Outstanding Website Development from the Web Marketing Association at the annual WebAward competition.






MerckSource was honored at the Healthcare Internet Conference in Atlanta, receiving the 2006 Gold eHealthcare Leadership Award for best health/healthcare content.






MerckSource received the 2006 WWW site Award of Excellence from the Health Improvement Institute.  This award honors excellence in health communications.






More Awards

Health News


Resource Library >> Health News >> Digestive Disorders
See Articles About

See All Health News    
Sign In or Register to Customize News

This information has been developed and provided by an independent third party source. Merck & Co., Inc., does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-Merck sources.

The news article below will expire on this website in 24 days.

Text Size:  A A A A A



Low Vitamin D May Harm the Bones of Ibd Patients

July 03, 2008


Michelle Rizzo

NEW YORK (Reuters Health) - Maintaining adequate vitamin D levels in the body may help guard against bone disease in patients with inflammatory bowel disease (IBD), according to a study in which researchers found a link between inadequate vitamin D levels and lower bone mineral density in a group of IBD patients.

IBD refers to the inflammation of the large or small colon and is characterized by diarrhea, abdominal pain and cramping, bloody stool, weight and appetite loss, and ulceration of the bowel lining. Crohn's disease and ulcerative colitis are two common types of inflammatory bowel disease.

A higher incidence of osteoporosis and fractures is a recognized complication of IBD, but the role of vitamin D insufficiency in IBD-related bone disease is uncertain.

Dr. William D. Leslie and colleagues from the University of Manitoba, Winnipeg, Canada, identified adults recently diagnosed with IBD and measured bone mineral density and vitamin D levels in a subgroup of 101 subjects.

Only 22 (22 percent) had optimal vitamin D levels, they found. Six patients, or 6 percent, had deficient levels, 38 (38 percent) had insufficient levels, and 35 (35 percent) had marginal levels.

Higher vitamin D levels were associated with greater bone density; lower levels with reduced bone density.

In 94 of the 101 subjects who had repeat BMD measurements roughly 2 years later, researchers saw a positive correlation between a gain in BMD in that interval and vitamin D levels.

"Early optimization of vitamin D may help to prevent bone disease in inflammatory bowel disease," Leslie commented to Reuters Health.

His group's next step, he said, "is to see whether poor vitamin D status or the degree of activity in a patient's inflammatory bowel disease lead to progressive loss in bone density."

SOURCE: American Journal of Gastroenterology, June 2008.


Back To Top

See All Health News